The pathogenesis of neonatal purpura is probably different from that of idiopathic thrombocytopenic purpura; hence cases of neonatal purpura have not been included in this article.
Purpura was originally described by Werlhof in 1775, but it was not until more than 100 years later that the association with thrombocytopenia was recognized (Osler, 1874; Krauss, 1883; Hayem, 1891) . The possible role of the spleen in causation was suggested by Frank in 1915 , and in the following year Kaznelson (1916) first suggested splenectomy as a method of treatment. As early as 1921 Bedson suggested that an auto-immune mechanism might be present, and this has been reconsidered recently (Evans and Duane, 1949; Harrington, Minnich, Hollingsworth and Moore, 1951;  Harrington, Sprague, Minnich, Moore, Ahlvin and Dubach, 1953) .
The purpose of the present study is to define the natural history of the disease and to decide whether clinical, haematological or serological features enable an accurate diagnosis and prognosis to be made early in the disease and whether such observations facilitate the management of individual cases.
Material and Method During the years [1943] [1944] [1945] [1946] [1947] [1948] [1949] [1950] [1951] [1952] [1953] [1954] [1955] [1956] [1957] [1958] 114 children attending this department were diagnosed as suffering from idiopathic thrombocytopenic purpura. Eighty have been observed by us during their entire illness and a further 30 during the major part. The details of the remaining four cases have been obtained entirely from the hospital records. Although this material represents all Tyneside cases referred to hospital in whom the diagnosis of idiopathic thrombocytopenic purpura was made, it cannot be claimed that it is necessarily complete.
The following investigations were carried out: The platelet level was estimated by Lempert's technique;* the capillary fragility by the method of Hess or the negative pressure method (G. A. Smart, 1954, personal communication) ; the bleeding time was measured by Duke's method and clot retraction by the method of Butz-Olsen.
Bone marrow examination was carried out in all patients in whom splenectomy was contemplated, but otherwise only in cases presenting diagnostic difficulty.
Tests for platelet antibodies were performed by two methods:
A. Direct Platelet Agglutination. Freshly collected serum was inactivated by absorption with barium sulphate. Serial dilutions in saline were made to 10 tubes. An equal volume of washed platelet suspension in E.D.T.A./Triton WR 1339/saline media was added to each. The mixture was incubated at 370 C. for one ARCHIVES OF DISEASE IN CHILDHOOD hour and any resulting agglutination was read microscopically.
B. Tanned Sheep Erythrocyte Agglutination. This is a modification of the technique described by KissmeyerNielsen (1953) . Sheep red cells treated with a dilute solution of tannic acid were coated by exposure to a platelet homogenate. The sensitized cells were suspended in serial dilutions of test sera in tubes 5 x 50mm. held in racks at an angle of 30 degrees. After three hours at room temperature the results were read macroscopically, the agglutinated cells adhering to the posterior wall of the tube, whereas non-agglutinated cells sedimented to the bottom, leaving clear supernatant fluid.
A positive control using immune rabbit anti-platelet serum and a negative control using the observer's serum were included with each batch of tests.
Finally, as the Registrar-General's returns suggested that the national death rate was much higher than that observed in this series we obtained copies of the death certificates of children registered as dying from idiopathic thrombocytopenic purpura in England and Wales during the years 1955-56. Essential clinical and haematological details of these cases were obtained from the doctor concerned and were studied to decide the actual cause of death and especially the stage of the illness at which death occurred.
Results
Purpura was classified as 'acute' in 83 patients and 'chronic' in 31.
Incidence. In Fig. 1 we have shown the yearly distribution of cases during the period under consideration, and in Figs. 2 and 3 the seasonal and age distribution of the acute and chronic varieties.
The apparent incidence has not been uniform over the years for there are three well-defined peaks, the highest being in recent years, a feature also noted by other workers (Clement and Diamond, 1953) .
The seasonal frequency varied with the type of purpura; chronic cases occurred all the year round and acute cases were most common in the spring and autumn.
The age distribution was the same for both the acute and chronic variety. Both were most common in young children with a maximum incidence at 7 years; similar observations have been made by Clement and Diamond (1953) .
No differences associated with sex were noticed. Once the platelet count has returned to normal remission is usually permanent, although in two instances further relapse occurred. One girl presented at the age of 7 years with haematuria and severe bruising, but within seven weeks she had completely recovered and her platelet count was 300,000 per c.mm. Three months later, however, she had a further episode of haematuria associated with thrombocytopenia. Recovery occurred within five weeks and has been maintained now for two years. The other, also a girl, presented at 5 years with bruising and petechiae following an infective illness five weeks before. Spontaneous recovery occurred within three months, but further bruising associated with thrombocytopenia recurred one month later. This relapse lasted only four weeks, since when the child has been perfectly well for two years.
The remaining 78 survivors have been kept under observation for periods of three to 18 years, and half of them for more than 10 years. None have relapsed. On their last visit three had platelet counts of only 150,000 per c.mm., but the remainder were in the range of 200-500,000 per c.mm., with an overall average of 300,000 per c.mm.
The remaining 31 cases were classified as chronic purpura.
One child who developed purpura in infancy died after one and a half years from a presumed cerebral haemorrhage. In view of her age splenectomy was not performed and corticosteroids were not available at this time.
Of the remainder, 16 have been treated by splenectomy. The other 14 have been observed for periods varying from three to 12 years (average five years) during which the average platelet level has been 63,000 per c.mm. Splenectomies were not performed because of the potential risk of infection after operation and because their symptoms were minimal, e.g. W.B., a manual worker now aged 22 years, developed idiopathic thrombocytopenic purpura at the age of 10 years. During the 12 years of observation his platelet count has never been higher than 40,000 per c.mm., but apart from excessive oozing following teeth extraction he has had no disability. Some are females who have passed puberty without excessive menstrual bleeding.
Management
When planning the conduct of any individual case of idiopathic thrombocytopenic purpura one must bear in mind that the risk of death is greatest in the initial acute phase, although it is present as long as thrombocytopenia persists. One in three cases persist indefinitely, but spontaneous recovery will occur within one year of onset in the other two.
Symptomatic treatment is often indicated and 25% of our patients had received antibiotics for upper respiratory infections before coming into hospital. No effect on the purpura was evident.
Blood transfusion was given only if blood loss had been sufficient to produce anaemia or shock; it was needed in the acute initial phase in 13 patients. Twelve additional children needed transfusion during the chronic stage of the disease. The urgency of transfusion usually precluded the use of platelet-rich blood, but in any case we think that this is only rarely indicated for any effect on the platelet level is trivial and short-lived. Moreover, injected platelets may lead to the development of platelet antibody. On only two occasions did we use platelet-rich blood, once because of persistent bleeding from a tooth socket and once as cover for teeth extraction. The haemostatic effect in the first boy was dramatic, although no rise in platelet count was evident. The second boy had little bleeding at operation, but this was also the case in six out of eight other children undergoing teeth extraction. The other two required transfusion because of persistent bleeding.
Corticosteroids. We have only tried corticosteroids in selected cases. Seven were treated during the initial acute phase, three when first seen but when purpura had already been present for one to three months, and before splenectomy in five cases of chronic purpura.
Usually we have given 200 mg. of cortisone or 40-50 mg. of prednisone daily during the first week of treatment, the dosage being decreased during each succeeding week and not continued for more than one month in most patients.
Of the seven treated early, four remitted but three showed no improvement at all and developed chronic purpura. Of the four who responded, two did so within one week, one within a month, although symptomatic improvement was immediate, while the other had active bleeding during the first week of corticosteroid therapy, although remission was complete within one month.
Of the three patients with the longer history before treatment, one remitted within one month, but there was no effect at all in the other two.
Of the five given corticosteroids before splenectomy, one showed a slight decrease in bleeding IDIOPATHIC THROMBOC YTOPENIC PURPURA tendency and another a transient small rise in platelets. The other three derived no benefit at all.
One other child who developed an acute haemolytic anaemia with positive Coombs test during the course of chronic idiopathic thrombocytopenic purpura was treated with prednisone. The anaemia responded promptly, but neither the bleeding tendency nor platelet level was affected.
Splenectomy. Sixteen patients in this series were treated by splenectomy because of persistent thrombocytopenia of more than one year's duration, together with excessive bleeding. The remaining 14 with persistent thrombocytopenia, but with little disability have been left untreated.
Bone marrow examination before operation was carried out in all. The number of megakaryocytes was increased in five cases, decreased in four and normal in the remaining seven. Without exception the proportion of megakaryocytes actively producing platelets was markedly decreased. Two patients had a significant increase in eosinophils in the marrow. We did not find the myelogram helpful in predicting the probable response to splenectomy, nor did we find that the presence of platelet antibodies gave any indication of the likely response to splenectomy.
We estimated the platelet count and bleeding time at the start of operation, when the splenic pedicle was clamped, and at the end of operation in five cases. No significant change in either test was observed. In some cases, however, an increase in the platelet count was noted within 30 minutes of operation and counts in the order of 100,000 per c.mm. were occasionally recorded within three hours. Usually, however, a significant increase was only observed at about six hours and levels greater than 100,000 per c.mm. were reached within 24 hours.
Figs. 4 and 5 show the platelet response after splenectomy in five cases of idiopathic thrombocytopenic purpura and five cases of congenital spherocytic haemolytic anaemia.
It will be seen that in idiopathic thrombocytopenic purpura peak values were usually reached between three to eight days; thereafter they fell to low normal values which were maintained. The higher the initial response the higher the ultimate equilibrium (average 350,000), although one case with a poor initial platelet rise eventually responded equally well.
In congenital spherocytosis the response was slower, but similar maximal levels were achieved and many had values of more than 100,000 per c.mm. several years after operation.
Emergency splenectomy was performed in only one patient, a child aged 20 months. The illness presented with epistaxis, haematuria and melaena 10 days after an attack of measles. Bleeding concontinued for eight days at which stage splenectomy was performed. For two days there was some improvement, then epistaxis and melaena recurred, and on the seventh post-operative day jaundice developed. On the twelfth post-operative day the wound broke down and later a faecal fistula and pyopneumothorax developed. Bronchopneumonia supervened and the child died three weeks after operation. It is not possible to say to what extent splenectomy contributed to the severe infection, but it is certain that in this case it had little effect on the bleeding tendency. This case occurred before corticosteroids were available. The 16 patients treated by splenectomy have been followed up for periods of two to eight years. Initially all responded completely, but thrombocytopenia has recurred in two. Neither has serious disability, but platelet antibodies have been detected in both. 653 group.bmj.com on July 7, 2017 -Published by http://adc.bmj.com/ Downloaded from
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Two boys treated by splenectomy have had serious infection since, and it seems possible that this is a consequence of operation. One developed purpura at the age of 6 months and was admitted to hospital on four occasions because of bleeding before the age of 4 years. At this time he developed a Coombs positive haemolytic anaemia and was treated with corticosteroids before splenectomy was carried out. Thrombocytopenia persisted, although his anaemia subsided, but 18 months after operation he developed pneumococcal meningitis. In the five years since operation he has had further attacks of pneumococcal and influenzal meningitis, two generalized septicaemic illnesses and repeated respiratory infections with pneumonia on at least three occasions. The other boy first developed purpura at the age of 7 years and was treated by splenectomy at the age of 10 years. Three months after operation he developed a generalized pneumococcal septicaemia and was admitted in extremis within hours of onset with severe peripheral circulatory failure. A tracheotomy was required and he was treated with steroids and antibiotics; he survived after a prolonged illness. So severe had been the peripheral collapse that some of his toes suffered ischaemic necrosis and had to be amputated subsequently.
Death due to Idiopathic Thrombocytopenic Purpura in England and Wales in 1955 and Fifty-eight children under the age of 11 were registered as having died from idiopathic thrombocytopenic purpura in these two years.
Twenty-seven of these deaths were in fact due to anaphylactoid purpura. Details of 30 of the remaining 31 were obtained, but eight were excluded as there was insufficient evidence on which to make the diagnosis. Ten of the remaining 22 were newborn babies, four of these deaths being associated with severe congenital defects. There remained only 12 comparable with the present series; and eleven were due to intracranial haemorrhage and the other to massive bleeding into the gastrointestinal tract.
One death occurred after an illness of 21 months' duration, but all the others occurred within five months of the first symptom. Several died after an extremely short illness, e.g. one child died within 24 hours of the onset and five more within one week. Two children developed signs of cerebral irritation while at school and died within a few days. More than 50% of the deaths occurred within 12 days of the first symptom and the onset was sudden in all. It is of interest that eight of the 12 fatal cases were admitted because of mucous membrane haemorrhage, haematemesis, and melaena in five and haematuria in three, although all eight gave a history of previous bruising.
None of the deaths could be attributed to lack of treatment for as well as blood transfusion in nearly every case, eight received corticosteroids and three were treated by splenectomy. One child was treated by splenectomy in the acute phase because of signs of cerebral haemorrhage, but died shortly afterwards with extension of this; two were treated in the sub-acute phase but showed no response. One died immediately after operation due to bleeding into the bowel; the other child died from cerebral haemorrhage despite the continuous administration of corticosteroids.
Discussion
In this communication we are concerned only with idiopathic thrombocytopenic purpura in childhood.
The natural course of the illness varies, especially in different age groups, but even in childhood variation is common. Some recover completely within a few days; others die due to exsanguination or bleeding into vital organs, while in others symptoms may persist indefinitely. The acute selflimiting variety is common in childhood (Simpkiss and Cathie, 1954; Komrower and Watson, 1954) and comprised 75% of the present material.
Like other workers (Clement and Diamond, 1953; Simpkiss and Cathie, 1954; Lozner, 1954) we found an equal sex distribution, although the latter recorded a female to male ratio of 3 7 to 1 in adult cases. In the series reported by Komrower and Watson, 23 of the 24 acute cases recovered in three months; half of these recovered in six weeks. In the present series more than half recovered within one month, 85% in four months, but spontaneous recovery was observed as long as two and a half years after onset. Carpenter, Wintrobe, Fuller, Haut and Cartwright (1959) recorded spontaneous remission up to one year after onset, but none after this time.
Although acute idiopathic thrombocytopenic purpura may carry the better ultimate prognosis, the initial stage of this disease is most dangerous, for three of the four deaths in our material occurred shortly after onset and 14 children required blood transfusion. Komrower and Watson (1954) reviewed the literature concerning 278 cases of idiopathic thrombocytopenic purpura in childhood. Nineteen died, 17 within one month of the onset of symptoms. Of the remaining two deaths, one occurred 13 months after splenectomy and the other was due to chronic nephritis. As we have seen, there were 12 deaths from idiopathic thrombocyto-IDIOPATHIC THROMBOCYTOPENIC PURPURA penic purpura in childhood in England and Wales in 1955 and . Eleven died from cerebral haemorrhage and one from gastro-intestinal bleeding. The onset was sudden in all and over half died within 12 days of the first symptom in spite of active treatment, including blood transfusion, corticosteroids and splenectomy.
It seems, therefore, that while thrombocytopenia always carries a potential risk it is greatest in the early stage of the disease, especially when it is characterized by florid bruising and mucous membrane haemorrhage.
Energetic treatment is indicated in all such cases, but because of the tendency to spontaneous remission it is difficult to evaluate the true benefit of such treatment. Like Watson-Williams, MacPherson and Davidson (1958) we found that a short history, especially if the illness was preceded by infection, usually indicated acute idiopathic thrombocytopenic purpura, whereas a long history with an indeterminate time of onset indicated the chronic form. These authors thought that steroids hastened remission in the acute group, but it is probable that remission would have occurred in any case. The good results achieved by splenectomy in their cases could similarly be explained. Byrne (1950) and Elliott and Turner (1951) recommend splenectomy in the first attack of purpura, but in our opinion it should not be carried out early in the disease for the mortality in emergency splenectomy may be as high as 80% (Wintrobe, 1951; Komrower and Watson, 1954; Simpkiss and Cathie, 1954) .
In the past decade platelet transfusion has become a practical proposition (Hirsch and Gardner, 1952; Tullis, 1953; Klein, Toch, Farber, Freeman and Fiorentino, 1956; Gardner and Cohen, 1960; Tobin and Friedman, 1960) , but its value in idiopathic thrombocytopenic purpura is limited, for although the life of circulating platelets is about one week in normal people, it is probably only a matter of hours in patients with idiopathic thrombocytopenic purpura (Harrington et al., 1953; Stefanini, Chatterjea, Dameshek, Zannos and Santiago, 1952) . It has been suggested that the benefit may be out of proportion to and may outlast the number of circulating platelets (Lancet, 1953) . Platelet antibodies may develop in response to platelet transfusion and this may be a contraindication especially in idiopathic thrombocytopenic purpura (Sharp, 1956) . Although there may be a place for platelet transfusion in other thrombocytopenic states such as aplastic anaemia or after irradiation (Woods, Gamble, Furth and Bigelow, 1953) it is only necessary in exceptional circumstances in idiopathic thrombocytopenic purpura, since teeth extraction and splenectomy may be carried out in such patients without excessive bleeding.
If neither splenectomy nor platelet transfusion is indicated in the acute phase of purpura then we must rely on steroid therapy to control dangerous haemorrhage. Various workers (Robson and Duthie, 1950; Faloon, Greene and Lozner, 1952; Jacobson and Sohier, 1952; Wilson and Eisemann, 1952; Greene, Faloon and Lozner, 1953; Hiivermark and Nordenson, 1953; Lozner, 1953) consider that steroids rarely influence the platelet level, but produce their effect by decreasing capillary permeability. Carpenter et al. (1959) , however, reported complete remission in 38% of cases treated by steroids. Dameshek, Rubio, Mahoney, Reeves and Burgin (1958) went further and claimed complete remissions in 10 out of 11 patients with acute and 12 out of 19 patients with chronic disease; although all were not permanent, they said that further remissions could be produced and maintained by continuous therapy. In addition, they were of the opinion that prednisone was superior to cortisone or A.C.T.H.
Response is particularly good in children and in the acute form of purpura, but it seems to us that complete remission is more likely to be a natural feature of the disease rather than a result of steroids per se. Harrington et al. (1953) Splenectomy is a safe operation in chronic purpura, but it may predispose to infection in some individuals. Early reports suggested that this complication was restricted to young infants (King and Shumacker, 1952) , but recent observations have established that this risk is not restricted to any age group (Gofstein and Gellis, 1956; Smith, Erlandson, Schulman and Stern, 1956, 1957; Doan, Bouroncle and Wiseman, 1960; Lucas and Krivit, 1960; Robinson and Sturgeon, 1960) . Huntley (1958) reviewed 58 cases of splenectomy in infants and children of which 46 had been followed up satisfactorily. She suggested that infection was more likely in young children and especially so if the primary disease was one associated with an increased risk of infection; this is the case in Aldrich's syndrome (Aldrich, Steinberg and Campbell, 1954) .
Infection may occur years after splenectomy (Robinson and Sturgeon, 1960) . C. H. Smith (1958, personal communication) recommends prophylactic penicillin for at least two years after operation, and also that any infection which does occur should be treated energetically from the start. Carpenter et al. (1959) reported the development of disseminated lupus erythematosus in one of their cases, a risk previously reported by Dameshek et al. (1958) , but Doan et al. (1960) deny that this is a risk.
Three children in our series developed serious infections after splenectomy.
We consider that where symptoms are minimal splenectomy should be withheld and close supervision employed.
Not all cases of chronic idiopathic thrombocytopenic purpura treated by splenectomy are cured, and Lozner (1954) estimated that there was a 60% chance of cure, that a further 20% improved, but that 20% derived no benefit. On the other hand, Carpenter et al. (1959) reported satisfactory results in 81 % of their cases and in the present series 14 of the 16 cases treated by splenectomy were cured and the other two were improved, although thrombocytopenia recurred. Carpenter et al. (1959) reported relapse in two of their cases after a good initial response lasting over two years. Schwartz and Kaplan (1950) suggested that a raised eosinophil count in the marrow indicated an allergic background and that spontaneous remission was therefore probable. They suggested that splenectomy was indicated only if the eosinophil count was normal, but most workers have not been able to confirm this (Presley, Best and Limarzi, 1952;  Simpkiss and Cathie, 1954; Komrower and Watson, 1954) . Indeed, Lozner (1954) suggested that a raised eosinophil count indicated a good response. We did not find that the eosinophil count in blood or marrow was of any value. It has been suggested that the number or morphology of the megakaryocytes is of value in predicting response to splenectomy (Dameshek and Miller, 1946; Valentine, 1947 ), but we and many others have not found this (Diggs and Hewlett, 1948; Komrower and Watson, 1954; Simpkiss and Cathie, 1954) .
It is disappointing that the presence of platelet antibody does not help in predicting the probable response to treatment (Dameshek and Stefanini, 1955) . This was certainly borne out by our own observations, but it seems possible that such tests may be of most value in predicting the risk of neonatal thrombocytopenic purpura, even in the infants of mothers who have been treated, perhaps successfully, by splenectomy. Lozner (1953 Lozner ( , 1954 studied the value of giving steroids before carrying out splenectomy; no complications after operation were observed, but there was no correlation between the response to steroids and the response to splenectomy, and this is in accordance with our observations. Thrombocytopenia in childhood is a potentially dangerous condition. If there is any underlying cause this should be treated appropriately. Otherwise corticosteroids should be administered in adequate dosage at the onset unless symptoms are minimal or of long duration. If there is no response in a short period of time it is unlikely that there will be and as continuous steroid therapy may be dangerous it should be discontinued. If thrombocytopenia persists for more than one year splenectomy should be considered, for in 80% of cases it will often produce permanent benefit. There is a potential risk of severe infection after splenectomy which may be greater in infancy and in conditions with an infective element, but the risk in idiopathic thrombocytopenic purpura does not seem to be disproportionately high. The majority of the cases treated by splenectomy were under the care of Professor Andrew Lowdon.
